Researcher Profile

Shiro Akinaga

Publications

343

Citations

Co-Authors

Active Years

Publications

Open Access Journal Article ESMO Open Jan 01, 2016

Phase II study of erlotinib plus tivantinib (ARQ 197) in patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer just after progression on EGFR-TKI, gefitinib or erlotinib

Koichi Azuma · Tomonori Hirashima · Nobuyuki Yamamoto · Isamu Okamoto +12 more

10.1136/esmoopen-2016-000063 36 citations

Open Access Journal Article British Journal of Haematology Mar 02, 2015

Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study

Takashi Ishida · Tatsuro Jo · Shigeki Takemoto · Hitoshi Suzushima +17 more

10.1111/bjh.13338 240 citations

Journal Article Cancer Chemotherapy and Pharmacology Apr 22, 2014

A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors

Hiroshi Wakui · Noboru Yamamoto · Satoru Kitazono · Hidenori Mizugaki +8 more

10.1007/s00280-014-2467-z 41 citations

Journal Article The Journal of Steroid Biochemistry and Molecular Biolo... Feb 01, 2009

Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patients

Masayo Suzuki · Hiroyuki Ishida · Yukimasa Shiotsu · TAISUKE NAKATA +5 more

10.1016/j.jsbmb.2008.12.008 26 citations

Publication Timeline

2016

2015

2014

2009

Frequent Co-Authors

1×

1×

1×

1×

1×

1×

1×

1×

1×

1×